Breaking News on Pharmaceutical Technology

Protein therapeutics worth $77bn by 2011, says RNCOS

25-Aug-2009 - The global protein therapeutics market will be worth $77bn by 2011 with biogenerics playing an increasingly important role, according to a new survey by industry analysts RNCOS.

News in brief

GSK reports theft of 25,600 Advair inhalers

25-Aug-2009 - UK drug major GSK says that two lots of its respiratory drug Advair Diskus have been stolen from a distribution facility in Richmond, Virginia in the US.

People on the move: pharma manufacturing jobs

25-Aug-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sutro Biopharma Lundbeck and AmerisourceBergen.

Will Lonza's $460m Patheon offer trigger bidding war?

24-Aug-2009 - Canadian contractor Patheon has welcomed the $460m (€321m) takeover offer from Switzerland's Lonza that could, according to some observers, spark a bidding war with rival suitor, US group JLL Patheon Holdings.

Warner Chilcott may pay $3bn for P&G drug unit

24-Aug-2009 - Woman’s healthcare and dermatology group Warner Chilcott will unveil plans to buy P&G’s prescription drug division for $3bn (€2.1bn) according to a number of media reports.

News in brief

MHRA orders recall of 100 batches of Karib Kemi Pharm drugs

20-Aug-2009 - The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has ordered the recall of 100 batches of drugs sold by generics firm Karib Kem Pharm.

Pfizer and Private Access team up for trial recruitment website

20-Aug-2009 - US drug giant Pfizer has joined the growing list of organisations seeking to boost trial recruitment via the web, teaming up with IT firm Private Access to create a website designed to “increase clinical trial awareness and participation.”

Eastern Europe drug market worth $41bn by 2014; but rules complex

19-Aug-2009 - Eastern Europe’s pharmaceutical market is growing at an impressive rate, but the complex regulatory rules being introduced may make it a less attractive proposition that it first appears, according to a new study by Business Insights.

Philippine FDA will cut registration time, says health sec

19-Aug-2009 - The world’s newest pharma industry regulatory body was set up in Phillipines yesterday with the foundation of a new agency modelled on the US FDA.

People on the move: pharma manufacturing jobs

17-Aug-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Millipore, AM Technology and Alder Pharmaceuticals.

News in brief

Gilead to close Colorado offices

13-Aug-2009 - Gilead Sciences is laying off up to 66 people as it closes its offices in Boulder and Westminster, Colorado, US to consolidate its operations in California.

People on the move: pharma manufacturing jobs

11-Aug-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including mass director resignations at Gentium and executive lay-offs at Ambrilia.

France to lead Euro API growth

06-Aug-2009 - France will lead growth in the European API market, according to a new report that believes the government’s cost-containment measures will put increased focus on the nation’s generic sector.

NAFDAC ups anti-counterfeiting actions

06-Aug-2009 - Nigeria is collaborating with Interpol and setting up offices in India to curb the flow of counterfeits, in particular allegedly China produced fakes labelled “Made in India”, according to media reports.

Pharma: people on the move

03-Aug-2009 - in-PharmaTechnologist presents its latest round-up of movements in the pharmaceutical sector, including a new CEO at Caraco, appointments at Mylan and the return of the “Viking boss”.

JLL bid “irrelevant”, says Patheon after win in Canadian Courts

29-Jul-2009 - In the latest twist in an increasing bitter takeover battle, the Ontario Superior Court of Justice has rejected JLL’s bid to oust directors elected to the board of Canadian CMO Patheon in April.

Caraco posts loss following cGMP issues

29-Jul-2009 - The financial impact of Caraco’s cGMP compliance issues have been revealed in its Q1 results, which saw a $14m (€9.9m) operating income in 2008 turn into a $14m loss this year.

Pfizer to settle Trovan suit this week, say Nigerian authorities

28-Jul-2009 - This week, US drug giant Pfizer will sign an out of court settlement relating to the 1996 trial of its candidate meningitis vaccine treatment Trovan (trovafloxacin), according to Nigerian authorities.

News in brief

Sanofi may sell Alnwick R&D facility

28-Jul-2009 - French drugmaker Sanofi-Aventis may put its Alnwick Research Centre in Northumberland, UK up for sale, according various media reports.

KV hires restructuring and bankruptcy firm

28-Jul-2009 - KV Pharmaceutical has hired a firm specialising in restructuring and bankruptcy and said “there are significant uncertainties regarding its ability to continue as a going concern during the upcoming fiscal year”.

Pharma: people on the move

28-Jul-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharmaceutical sector, including appointments at Novavax, Halozyme and Abraxis.

EMEA fast tracking H1N1 vaccine data

27-Jul-2009 - The EMEA is fast tracking the review of data on H1N1 pandemic vaccines to ensure it has checked submissions before the northern hemisphere flu season, which starts in September.

Sanofi to buy Indian vaccine biz

27-Jul-2009 - Sanofi-Aventis is continuing to expand in emerging markets by agreeing to acquire Indian vaccine manufacturer Shantha Biotechnics in a deal that values the company at €550m ($784m).

News in brief

IMS Health to shed 850 jobs

27-Jul-2009 - Industry analyst IMS Health will cut 850 jobs over the next 12 to 15 months, including 170 positions at its US operations.